Effects of Exercise on Long-Range Autocorrelations in Parkinson's Disease
NCT ID: NCT02419768
Last Updated: 2016-01-28
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
UNKNOWN
Clinical Phase
NA
Total Enrollment
50 participants
Study Classification
INTERVENTIONAL
Study Start Date
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Parkinson's disease (PD) is one of the most common neurodegenerative disorders. The parkinsonian gait is characterized by reducted stride length and gait speed, postural disorders (with a high risk of falling) and a modification of stride duration variability. This variability can be assessed by its magnitude (SD and CV) and its temporal organization (long-range autocorrelations). Healthy human gait presents with an interdependency between consecutive cycles that can span over hundreds of strides (long-range autocorrelations). Numerous observations plead for a relation between long-range autocorrelations and functional abilities of the system. Complementary to drugs, rehabilitation becomes an important way to treat PD.
The aim of our study is to assess by a controlled, randomized, single blinded clinical study, the effect of physical exercise on stride duration variability, neurological impairments and walking abilities of parkinsonian patients.
Physical exercise program will include 30 sessions spread over 15 weeks following the guidelines. Long-range correlations analysis, including the study of Hurst and α exponents, will be performed on a minimum of 512 consecutive cycles. Finally, the functional assessment of the parkinsonian patient will be done according to International Classification of Functioning Disability and Health (ICF).
The aim of our study is to assess by a controlled, randomized, single blinded clinical study, the effect of physical exercise on stride duration variability, neurological impairments and walking abilities of parkinsonian patients.
Physical exercise program will include 30 sessions spread over 15 weeks following the guidelines. Long-range correlations analysis, including the study of Hurst and α exponents, will be performed on a minimum of 512 consecutive cycles. Finally, the functional assessment of the parkinsonian patient will be done according to International Classification of Functioning Disability and Health (ICF).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gait Control in Parkinson Disease
NCT05908279
Parkinson Disease
RECRUITING
Effect of Haptic Cueing on Long-Range Autocorrelations in Parkinson's Disease Gait Variability
NCT05790759
Parkinson Disease
Gait, Unsteady
COMPLETED
NA
The ParkCycle Study: Aerobic Exercise in PD
NCT01562496
Parkinson's Disease
COMPLETED
NA
Physical Training Induced Plasticity of Motor Control Mechanisms in Parkinson's Disease Patients
NCT03753503
Parkinson Disease
Physical Activity
COMPLETED
NA
Stability and Balance in Locomotion Through Exercise
NCT01856244
Parkinson's Disease
COMPLETED
PHASE1
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
BACKGROUND
One of the most common features of human movement is its variability across multiple repetition of the same rhythmic task (1). In humans, many periodic signals, such as gait, heartbeat, respiratory and neuronal activities are characterized by their temporal complexity, fluctuating in a complex manner over time. Although fluctuations between cycles could appear to vary randomly, without apparent correlations between cycles, healthy systems possess the memory of preceding values of the series displaying a complex temporal structure.
In order to assess variability in physiological time series, several mathematical methods can be used. On one hand, classical mathematical methods, usually applied on shorter time series (tens of data points), quantify the fluctuation magnitude in a set of values independently of their order in the distribution, by computing the standard deviation (SD) and the coefficient of variation (CV). On the other hand, more complex mathematical methods, applied on longer time series (≥512 cycles), can be used to assess the fluctuation dynamics over time (3). These latter methods have demonstrated that variability of numerous physiological signals (cardiac and respiratory rhythm or locomotor activities e.g.) exhibit long-range autocorrelations, whereby the statistical inter-dependency between cycles spans of a very large number of cycles (14).
This temporal organization of variability is thus an intrinsic property within numerous biological systems. Moreover, it could provide insight into the neurophysiological organization and into the regulation of these systems (32). Recent studies claimed that these fluctuations, included in an optimal range, would represent the underlying physiologic capability to make flexible adaptations to everyday stresses placed on the human body (32). Therefore, the presence of such temporal dynamics is thought to be a critical marker of health and their breakdown as an index of pathological condition (18, 25, 32). In human heart rate for instance, deviations from an optimum of variability in either the direction of randomness (atrial fibrillation e.g.) or the over-regularity (congestive heart failure e.g.) indicate the loss of the adaptive capabilities of the system (9, 32).
Alongside, some central nervous system diseases influence the variability, especially, of gait. Indeed, neurodegenerative disorders such as Parkinson and Huntington diseases are characterized, among others, by a modification of walking variability (observed by a breakdown of long-range autocorrelations) and a high risk of falling. Although the origin of long-range autocorrelation remains unknown, their breakdown in such diseases suggests a central control mechanism (8, 11, 13, 16, 17, 36).
RESEARCH PROJECT
Affecting about 1% of the population over the age of 60, Parkinson's disease (PD) is one of the most common neurodegenerative disorders. PD is progressive in nature, and so patients face increased difficulties with activities of daily living and various aspects of mobility such as gait, transfers, balance, and posture. Ultimately, this leads to decreased independence, inactivity, and social isolation, resulting in reduced quality of life. Consequently, the improvement of locomotion is one of the most important aims of the management of PD.
The management of PD has traditionally centered on drug therapy, with levodopa viewed as the "gold standard" treatment. However, even with optimal medical management, parkinsonian patients experience deterioration in body function, daily activities and participation. For this reason, support has been increasing for the inclusion of rehabilitation therapies as an adjuvant to pharmacological and neurosurgical treatment. Indeed, regular physical activity slows down the progression and decrease the fall risk. Moreover, exercise has demonstrated its effectiveness for both preservation of functional abilities and prevention of complications (cardiovascular, osteoporosis,…).
Until now, few studies have included the analysis of variability in the functional assessment of patients presenting a neurological disease, such as PD. Yet, walking disorders and falls represent not only an important cost for the society but also a sizeable individual risk of morbi/mortality. An appropriate rehabilitation program should allow for reduction at once the risks and costs resulting from these disorders. The investigator hypothesize that the analysis of walking variability could be useful as clinical tool in the assessment of fall risk and as assessment tool of the therapeutic effectiveness (medication and/or physical exercise) in PD. Therefore, the aims of this study are (1) to assess the influence of physical exercise on human walking variability and (2) to study its potential correlations with walking abilities and neurological impairments of parkinsonian patients.
Patients
The investigators will recruit 50 patients with idiopathic Parkinson's disease from the department of Neurology of Cliniques universitaires Saint-Luc (Brussels, Belgium) The study is approved by the ethics committee. All patients will give informed written consent to the study. Eligibility criteria are: diagnosis idiopathic Parkinson (according to the Brain Bank criteria of the United Kingdom Parkinson's Disease Society), disease severity (according to modified Hoehn \& Yahr stages I to IV), absence of dementia (Minimal Mini Mental State Examination score of 24 or higher), stable drug usage in the last 4 weeks and adequate vision and hearing, achieved using corrective lenses and/or hearing aid if required. Patients will be excluded if they have severe co-morbidity, other neurological problems, acute medical problems (e.g. MI, diabetes) and joint problems affecting mobility, and unpredictable "Off"-periods (score \>2, MDS-UPDRS item 4.5).
Procedure
The present study is a controlled, randomized, single blinded clinical study with a crossover design. The control group will not change its usual physical activity whereas the intervention group will benefit from the physical exercise program. This latter will include 30 sessions of circuit-group training of 60 min (twice a week) spread over 15 weeks. Then, the two groups will be crossed. According to the recent guidelines, the program will include a specific work on balance, posture, gait, fitness, dual tasks and stretching. All sessions will be performed at an adequate intensity (i.e. 60-80% of predicted maximal heart rate). At least 512 cycles will be recorded (at a high sampling rate (512 Hz)) on a treadmill at a self-selected comfortable speed using a unidimensional accelerometer taped on the right lateral malleolus.
Functional assessment based on the 3 domains of the International Classification of Functioning, Disability and Health (ICF)
Patients will be assessed before intervention (T0) and at 15 (T1), 30 (T2), 45 (T3) and 60 weeks (T4) among the 3 ICF domains:
Impairments will assessed by MDS-UPDRS, an instrumented gait analysis (kinematic, kinetic, electromyographic and energetic) (18), the 6 minute walk distance, the 10 meter walk test, the ABC-Scale and the BESTest (including the Functional Reach Test, the Push \& Release and the Get Up \& Go test).
Activities, participation and quality of life will be evaluated the Impact on Participation and Autonomy Questionnaire (IPAQ) and a fall diary.
Walking variability analysis
Revolution time variability will be appreciated by classical and complex mathematical methods. Classical mathematical methods (standard deviation, coefficient of variation) allow for evaluating the fluctuation magnitude, while complex mathematical methods (long-range autocorrelations) assess the dynamics of fluctuations over time (3).
The presence of long-range autocorrelations will be evaluated using the integrated approach proposed by Rangarajan and Ding and validated by Crevecoeur et al. in the context of physiological time series. These methods are described in greater details elsewhere. Briefly, the Hurst exponent (H) will be calculated using the rescaled range analysis and the α exponent will be evaluated using the power spectral density of the time series. For each time series, both methods will be applied to sequences of 512 consecutive gait strides.
In theory, the exponents H and α are asymptotically related by the relation H. Hence, the integrated approach consists of separately computing H and α, and verifying that these two parameters are consistent through the equation d=H-(1+α)/2=0. A value of d ≤ 0.10 is considered acceptable since the asymptotic parameters are evaluated on finite time series.
In summary, the following three conditions must be satisfied to conclude for the presence of long-range autocorrelations :
H \> 0.5; α is significantly different from 0 and lower than 1; and d ≤ 0.10
When inconsistencies appear between H and α, the investigators will use the randomly shuffled surrogate data test to reject the null hypothesis that the series under investigation has no temporal structure (i.e. uncorrelated random process).
PERSPECTIVES
By studying the influence of physical exercise on human walking variability and its potential correlations with walking abilities and neurological impairments of parkinsonian patients, the investigators hope to demonstrate that the analysis of walking variability could be use as a clinical tool in the assessment of fall risk and as an assessment tool of the therapeutic effectiveness (medication and/or physical exercise) in PD.
One of the most common features of human movement is its variability across multiple repetition of the same rhythmic task (1). In humans, many periodic signals, such as gait, heartbeat, respiratory and neuronal activities are characterized by their temporal complexity, fluctuating in a complex manner over time. Although fluctuations between cycles could appear to vary randomly, without apparent correlations between cycles, healthy systems possess the memory of preceding values of the series displaying a complex temporal structure.
In order to assess variability in physiological time series, several mathematical methods can be used. On one hand, classical mathematical methods, usually applied on shorter time series (tens of data points), quantify the fluctuation magnitude in a set of values independently of their order in the distribution, by computing the standard deviation (SD) and the coefficient of variation (CV). On the other hand, more complex mathematical methods, applied on longer time series (≥512 cycles), can be used to assess the fluctuation dynamics over time (3). These latter methods have demonstrated that variability of numerous physiological signals (cardiac and respiratory rhythm or locomotor activities e.g.) exhibit long-range autocorrelations, whereby the statistical inter-dependency between cycles spans of a very large number of cycles (14).
This temporal organization of variability is thus an intrinsic property within numerous biological systems. Moreover, it could provide insight into the neurophysiological organization and into the regulation of these systems (32). Recent studies claimed that these fluctuations, included in an optimal range, would represent the underlying physiologic capability to make flexible adaptations to everyday stresses placed on the human body (32). Therefore, the presence of such temporal dynamics is thought to be a critical marker of health and their breakdown as an index of pathological condition (18, 25, 32). In human heart rate for instance, deviations from an optimum of variability in either the direction of randomness (atrial fibrillation e.g.) or the over-regularity (congestive heart failure e.g.) indicate the loss of the adaptive capabilities of the system (9, 32).
Alongside, some central nervous system diseases influence the variability, especially, of gait. Indeed, neurodegenerative disorders such as Parkinson and Huntington diseases are characterized, among others, by a modification of walking variability (observed by a breakdown of long-range autocorrelations) and a high risk of falling. Although the origin of long-range autocorrelation remains unknown, their breakdown in such diseases suggests a central control mechanism (8, 11, 13, 16, 17, 36).
RESEARCH PROJECT
Affecting about 1% of the population over the age of 60, Parkinson's disease (PD) is one of the most common neurodegenerative disorders. PD is progressive in nature, and so patients face increased difficulties with activities of daily living and various aspects of mobility such as gait, transfers, balance, and posture. Ultimately, this leads to decreased independence, inactivity, and social isolation, resulting in reduced quality of life. Consequently, the improvement of locomotion is one of the most important aims of the management of PD.
The management of PD has traditionally centered on drug therapy, with levodopa viewed as the "gold standard" treatment. However, even with optimal medical management, parkinsonian patients experience deterioration in body function, daily activities and participation. For this reason, support has been increasing for the inclusion of rehabilitation therapies as an adjuvant to pharmacological and neurosurgical treatment. Indeed, regular physical activity slows down the progression and decrease the fall risk. Moreover, exercise has demonstrated its effectiveness for both preservation of functional abilities and prevention of complications (cardiovascular, osteoporosis,…).
Until now, few studies have included the analysis of variability in the functional assessment of patients presenting a neurological disease, such as PD. Yet, walking disorders and falls represent not only an important cost for the society but also a sizeable individual risk of morbi/mortality. An appropriate rehabilitation program should allow for reduction at once the risks and costs resulting from these disorders. The investigator hypothesize that the analysis of walking variability could be useful as clinical tool in the assessment of fall risk and as assessment tool of the therapeutic effectiveness (medication and/or physical exercise) in PD. Therefore, the aims of this study are (1) to assess the influence of physical exercise on human walking variability and (2) to study its potential correlations with walking abilities and neurological impairments of parkinsonian patients.
Patients
The investigators will recruit 50 patients with idiopathic Parkinson's disease from the department of Neurology of Cliniques universitaires Saint-Luc (Brussels, Belgium) The study is approved by the ethics committee. All patients will give informed written consent to the study. Eligibility criteria are: diagnosis idiopathic Parkinson (according to the Brain Bank criteria of the United Kingdom Parkinson's Disease Society), disease severity (according to modified Hoehn \& Yahr stages I to IV), absence of dementia (Minimal Mini Mental State Examination score of 24 or higher), stable drug usage in the last 4 weeks and adequate vision and hearing, achieved using corrective lenses and/or hearing aid if required. Patients will be excluded if they have severe co-morbidity, other neurological problems, acute medical problems (e.g. MI, diabetes) and joint problems affecting mobility, and unpredictable "Off"-periods (score \>2, MDS-UPDRS item 4.5).
Procedure
The present study is a controlled, randomized, single blinded clinical study with a crossover design. The control group will not change its usual physical activity whereas the intervention group will benefit from the physical exercise program. This latter will include 30 sessions of circuit-group training of 60 min (twice a week) spread over 15 weeks. Then, the two groups will be crossed. According to the recent guidelines, the program will include a specific work on balance, posture, gait, fitness, dual tasks and stretching. All sessions will be performed at an adequate intensity (i.e. 60-80% of predicted maximal heart rate). At least 512 cycles will be recorded (at a high sampling rate (512 Hz)) on a treadmill at a self-selected comfortable speed using a unidimensional accelerometer taped on the right lateral malleolus.
Functional assessment based on the 3 domains of the International Classification of Functioning, Disability and Health (ICF)
Patients will be assessed before intervention (T0) and at 15 (T1), 30 (T2), 45 (T3) and 60 weeks (T4) among the 3 ICF domains:
Impairments will assessed by MDS-UPDRS, an instrumented gait analysis (kinematic, kinetic, electromyographic and energetic) (18), the 6 minute walk distance, the 10 meter walk test, the ABC-Scale and the BESTest (including the Functional Reach Test, the Push \& Release and the Get Up \& Go test).
Activities, participation and quality of life will be evaluated the Impact on Participation and Autonomy Questionnaire (IPAQ) and a fall diary.
Walking variability analysis
Revolution time variability will be appreciated by classical and complex mathematical methods. Classical mathematical methods (standard deviation, coefficient of variation) allow for evaluating the fluctuation magnitude, while complex mathematical methods (long-range autocorrelations) assess the dynamics of fluctuations over time (3).
The presence of long-range autocorrelations will be evaluated using the integrated approach proposed by Rangarajan and Ding and validated by Crevecoeur et al. in the context of physiological time series. These methods are described in greater details elsewhere. Briefly, the Hurst exponent (H) will be calculated using the rescaled range analysis and the α exponent will be evaluated using the power spectral density of the time series. For each time series, both methods will be applied to sequences of 512 consecutive gait strides.
In theory, the exponents H and α are asymptotically related by the relation H. Hence, the integrated approach consists of separately computing H and α, and verifying that these two parameters are consistent through the equation d=H-(1+α)/2=0. A value of d ≤ 0.10 is considered acceptable since the asymptotic parameters are evaluated on finite time series.
In summary, the following three conditions must be satisfied to conclude for the presence of long-range autocorrelations :
H \> 0.5; α is significantly different from 0 and lower than 1; and d ≤ 0.10
When inconsistencies appear between H and α, the investigators will use the randomly shuffled surrogate data test to reject the null hypothesis that the series under investigation has no temporal structure (i.e. uncorrelated random process).
PERSPECTIVES
By studying the influence of physical exercise on human walking variability and its potential correlations with walking abilities and neurological impairments of parkinsonian patients, the investigators hope to demonstrate that the analysis of walking variability could be use as a clinical tool in the assessment of fall risk and as an assessment tool of the therapeutic effectiveness (medication and/or physical exercise) in PD.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Parkinson's Disease
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
CROSSOVER
Blinding Strategy
SINGLE
Outcome Assessors
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Physical Exercise
All patients will receive a circuit-group training including a specific work of balance, posture, gait, fitness, dual tasks and stretching.
Group Type
EXPERIMENTAL
Physical Exercise
Intervention Type
OTHER
The physical exercise program will include 30 sessions of 60 minutes (twice a week). According to the recent guidelines, the program will include a specific work on balance, posture, gait, fitness, dual tasks and stretching.
Control
All patients will not change their physical activities
Group Type
NO_INTERVENTION
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical Exercise
The physical exercise program will include 30 sessions of 60 minutes (twice a week). According to the recent guidelines, the program will include a specific work on balance, posture, gait, fitness, dual tasks and stretching.
Intervention Type
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis idiopathic Parkinson according to the Brain Bank criteria of the United Kingdom Parkinson's Disease Society
* Disease severity according to modified Hoehn \& Yahr stages I to IV
* Absence of dementia Minimal Mini Mental State Examination score of 24 or higher
* Stable drug usage in the last 4 weeks
* Adequate vision and hearing, achieved using corrective lenses and/or hearing aid if required
* Disease severity according to modified Hoehn \& Yahr stages I to IV
* Absence of dementia Minimal Mini Mental State Examination score of 24 or higher
* Stable drug usage in the last 4 weeks
* Adequate vision and hearing, achieved using corrective lenses and/or hearing aid if required
Exclusion Criteria
* Severe co-morbidity, other neurological problems, acute medical problems (e.g. MI, diabetes) and joint problems affecting mobility
* Unpredictable "Off"-periods (score \>2, MDS-UPDRS item 4.5)
* Unpredictable "Off"-periods (score \>2, MDS-UPDRS item 4.5)
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lejeune
Professor
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thibault B. Warlop, Doctor
Role: PRINCIPAL_INVESTIGATOR
Université Catholique de Louvain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Université catholique de Louvain - Cliniques universitaires Saint-Luc
Woluwé-Saint-Lambert, Brussels Capital, Belgium
Site Status
RECRUITING
Countries
Review the countries where the study has at least one active or historical site.
Belgium
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Stergiou N, Decker LM. Human movement variability, nonlinear dynamics, and pathology: is there a connection? Hum Mov Sci. 2011 Oct;30(5):869-88. doi: 10.1016/j.humov.2011.06.002. Epub 2011 Jul 29.
Reference Type
BACKGROUND
Hausdorff JM. Gait dynamics, fractals and falls: finding meaning in the stride-to-stride fluctuations of human walking. Hum Mov Sci. 2007 Aug;26(4):555-89. doi: 10.1016/j.humov.2007.05.003. Epub 2007 Jul 5.
Reference Type
BACKGROUND
Hausdorff JM, Cudkowicz ME, Firtion R, Wei JY, Goldberger AL. Gait variability and basal ganglia disorders: stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease. Mov Disord. 1998 May;13(3):428-37. doi: 10.1002/mds.870130310.
Reference Type
BACKGROUND
Peng CK, Havlin S, Stanley HE, Goldberger AL. Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series. Chaos. 1995;5(1):82-7. doi: 10.1063/1.166141.
Reference Type
BACKGROUND
Goldberger AL, Amaral LA, Hausdorff JM, Ivanov PCh, Peng CK, Stanley HE. Fractal dynamics in physiology: alterations with disease and aging. Proc Natl Acad Sci U S A. 2002 Feb 19;99 Suppl 1(Suppl 1):2466-72. doi: 10.1073/pnas.012579499.
Reference Type
BACKGROUND
Bollens B, Crevecoeur F, Nguyen V, Detrembleur C, Lejeune T. Does human gait exhibit comparable and reproducible long-range autocorrelations on level ground and on treadmill? Gait Posture. 2010 Jul;32(3):369-73. doi: 10.1016/j.gaitpost.2010.06.011. Epub 2010 Jul 15.
Reference Type
BACKGROUND
Bollens B, Crevecoeur F, Detrembleur C, Guillery E, Lejeune T. Effects of age and walking speed on long-range autocorrelations and fluctuation magnitude of stride duration. Neuroscience. 2012 May 17;210:234-42. doi: 10.1016/j.neuroscience.2012.02.039. Epub 2012 Mar 5.
Reference Type
BACKGROUND
Crevecoeur F, Bollens B, Detrembleur C, Lejeune TM. Towards a "gold-standard" approach to address the presence of long-range auto-correlation in physiological time series. J Neurosci Methods. 2010 Sep 30;192(1):163-72. doi: 10.1016/j.jneumeth.2010.07.017. Epub 2010 Jul 21.
Reference Type
BACKGROUND
Diniz A, Wijnants ML, Torre K, Barreiros J, Crato N, Bosman AM, Hasselman F, Cox RF, Van Orden GC, Delignieres D. Contemporary theories of 1/f noise in motor control. Hum Mov Sci. 2011 Oct;30(5):889-905. doi: 10.1016/j.humov.2010.07.006. Epub 2010 Dec 31.
Reference Type
BACKGROUND
Dingwell JB, John J, Cusumano JP. Do humans optimally exploit redundancy to control step variability in walking? PLoS Comput Biol. 2010 Jul 15;6(7):e1000856. doi: 10.1371/journal.pcbi.1000856.
Reference Type
BACKGROUND
Gates DH, Dingwell JB. Peripheral neuropathy does not alter the fractal dynamics of stride intervals of gait. J Appl Physiol (1985). 2007 Mar;102(3):965-71. doi: 10.1152/japplphysiol.00413.2006. Epub 2006 Nov 16.
Reference Type
BACKGROUND
Hausdorff JM, Ashkenazy Y, Peng CK, Ivanov PC, Stanley HE, Goldberger AL. When human walking becomes random walking: fractal analysis and modeling of gait rhythm fluctuations. Physica A. 2001 Dec 15;302(1-4):138-47. doi: 10.1016/s0378-4371(01)00460-5.
Reference Type
BACKGROUND
Paterson K, Hill K, Lythgo N. Stride dynamics, gait variability and prospective falls risk in active community dwelling older women. Gait Posture. 2011 Feb;33(2):251-5. doi: 10.1016/j.gaitpost.2010.11.014. Epub 2010 Dec 16.
Reference Type
BACKGROUND
Gillespie LD, Robertson MC, Gillespie WJ, Sherrington C, Gates S, Clemson LM, Lamb SE. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD007146. doi: 10.1002/14651858.CD007146.pub3.
Reference Type
BACKGROUND
Keus SH, Munneke M, Nijkrake MJ, Kwakkel G, Bloem BR. Physical therapy in Parkinson's disease: evolution and future challenges. Mov Disord. 2009 Jan 15;24(1):1-14. doi: 10.1002/mds.22141.
Reference Type
BACKGROUND
Tomlinson CL, Patel S, Meek C, Herd CP, Clarke CE, Stowe R, Shah L, Sackley CM, Deane KH, Wheatley K, Ives N. Physiotherapy versus placebo or no intervention in Parkinson's disease. Cochrane Database Syst Rev. 2013 Sep 10;2013(9):CD002817. doi: 10.1002/14651858.CD002817.pub4.
Reference Type
BACKGROUND
Snijders AH, Bloem BR. Images in clinical medicine. Cycling for freezing of gait. N Engl J Med. 2010 Apr 1;362(13):e46. doi: 10.1056/NEJMicm0810287. No abstract available.
Reference Type
BACKGROUND
Snijders AH, Toni I, Ruzicka E, Bloem BR. Bicycling breaks the ice for freezers of gait. Mov Disord. 2011 Feb 15;26(3):367-71. doi: 10.1002/mds.23530. Epub 2011 Feb 1.
Reference Type
BACKGROUND
Warlop TB, Bollens B, Crevecoeur F, Detrembleur C, Lejeune TM. Dynamics of revolution time variability in cycling pattern: voluntary intent can alter the long-range autocorrelations. Ann Biomed Eng. 2013 Aug;41(8):1604-12. doi: 10.1007/s10439-013-0834-2. Epub 2013 May 28.
Reference Type
BACKGROUND
KARVONEN MJ, KENTALA E, MUSTALA O. The effects of training on heart rate; a longitudinal study. Ann Med Exp Biol Fenn. 1957;35(3):307-15. No abstract available.
Reference Type
BACKGROUND
Stoquart G, Detrembleur C, Lejeune T. Effect of speed on kinematic, kinetic, electromyographic and energetic reference values during treadmill walking. Neurophysiol Clin. 2008 Apr;38(2):105-16. doi: 10.1016/j.neucli.2008.02.002. Epub 2008 Mar 6.
Reference Type
BACKGROUND
Ernst M, Folkerts AK, Gollan R, Lieker E, Caro-Valenzuela J, Adams A, Cryns N, Monsef I, Dresen A, Roheger M, Eggers C, Skoetz N, Kalbe E. Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD013856. doi: 10.1002/14651858.CD013856.pub3.
Reference Type
DERIVED
Ernst M, Folkerts AK, Gollan R, Lieker E, Caro-Valenzuela J, Adams A, Cryns N, Monsef I, Dresen A, Roheger M, Eggers C, Skoetz N, Kalbe E. Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023 Jan 5;1(1):CD013856. doi: 10.1002/14651858.CD013856.pub2.
Reference Type
DERIVED
Warlop T, Detrembleur C, Buxes Lopez M, Stoquart G, Lejeune T, Jeanjean A. Does Nordic Walking restore the temporal organization of gait variability in Parkinson's disease? J Neuroeng Rehabil. 2017 Feb 21;14(1):17. doi: 10.1186/s12984-017-0226-1.
Reference Type
DERIVED
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IONS - Warlop - 01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
NCT04046276
UNKNOWN
NA
Exercise, Brain Imaging, Cognition, and Gait in Parkinsonism
NCT02231073
COMPLETED
NA
Study of Axial Mobility Exercises in Parkinson Disease
NCT00004760
COMPLETED
NA
Ambulatory Assessment of Motor State in Patients With Parkinson's Disease in Real Daily Life
NCT00184808
UNKNOWN
Effects of Aerobic Exercise in Parkinson's Disease
NCT00784563
COMPLETED
NA
Effects of Physical Activity on the Brain in Parkinson's Disease (PD)
NCT01741584
COMPLETED
NA
Study in Parkinson's Disease of Exercise
NCT01506479
COMPLETED
NA
Physical Activity in Patients With Parkinson's Disease: a "Disease Modifying" Intervention?
NCT05815524
TERMINATED
NA
Exercise Intervention and Dexterity in Parkinson
NCT01749917
COMPLETED
NA
Effects of Home Rehabilitation of Balance Based on Functional Exercises in People With Parkinson's Disease
NCT04963894
UNKNOWN
NA
Motor Learning in Parkinson's Disease: Underlying Effective Connectivity and Influential Factors
NCT04269577
ACTIVE_NOT_RECRUITING
NA
Exploring the Effects of Exercise on Memory and Cognition in Parkinson´s Disease
NCT06580977
RECRUITING
NA
ParKinWalk: Physical Activity and Long Group-walking for Parkinson's Disease
NCT04266782
COMPLETED
NA
Exercise and Parkinson's: Comparing Interventions and Exploring Neural Mechanisms
NCT01768832
COMPLETED
NA
Exercise for Adults With Parkinson Disease
NCT02615548
UNKNOWN
NA
Physical Activity on Neuroinflammation in Parkinson's Disease
NCT06977204
RECRUITING
Evaluation of Functional and Biochemical Effectiveness of a Strength Training Protocol in Parkinson's Disease
NCT07095400
NOT_YET_RECRUITING
NA
Movement Improves Brain Health and Cognition in Parkinson's Disease
NCT07299279
RECRUITING
NA
Flexible Reaching Control in Parkinson Disease
NCT05908266
RECRUITING
Effects of Nordic Walking Exercise on Gait, Motor/Non-motor Symptoms, and Exercise Biomarkers in Parkinson's Disease
NCT04237025
COMPLETED
NA
Effect of Exercise in Parkinsonism
NCT02598973
COMPLETED
NA
Exercise Study For People With Parkinson's Disease
NCT00387218
UNKNOWN
NA
Consolidation of Motor Learning of Writing Skills and Its Related Brain Activity Changes in Parkinson's Disease
NCT02288052
COMPLETED
NA
Dual Task Practice in Parkinson's Disease
NCT01375413
COMPLETED
PHASE3